摘要
目的探讨塞来昔布+骨创伤治疗仪治疗膝关节炎疼痛的疗效。方法将聊城市第三人民医院骨科门诊2015年1月-2017年1月收治的108例单侧早中期膝骨性关节炎患者随机分为观察组、对照组,每组54例。观察组口服塞来昔布+应用骨创伤治疗仪;对照组口服塞来昔布。比较两组患者临床疗效。结果末次随访时,观察组患者疼痛评分均低于对照组(t=3.21,P=0.00),观察组患者膝关节功能优于对照组(t=3.74,P=0.00),观察组总有效率88.89%高于对照组的77.78%(χ2=4.70,P=0.03)。结论塞来昔布联合骨创伤治疗仪治疗早中期膝骨性关节炎疼痛临床疗效显著,有效降低疼痛评分,能增进膝关节功能改善,值得临床应用。
Objective To observe the efficacy of celebrex + bone trauma therapy instrument on the pain of knee osteoarthritis. Methods A total of 108 cases with unilateral early-middle stage knee osteoarthritis admitted to the orthopedics department of Liaocheng Third People’s Hospital from January 2015 to January 2017 were selected. They were randomly divided into observation group and control group, with 54 cases in each group. The observation group received oral celecoxib + bone trauma treatment instrument. The control group received celecoxib orally. Then, the clinical efficacy of the two groups was compared. Results At the last follow-up, the pain scores of patients in the observation group were all lower than those in the control group(t=3.21, P=0.00). The knee function of the observation group was better than that of the control group(t=3.74, P=0.00). The total effective rate of the observation group was 88.89%,which was higher than that of the control group(77.78%)(χ~2=4.70, P=0.03). Conclusions Celebrex combined with bone trauma therapy instrum ent has significantly clinical effect on the pain of knee osteoarthritis in the early and middle stage. It effectively reduces the pain score and improves the knee joint function, which is worthy of clinical application.
作者
赵忠全
陈杰超
纪京博
王光忠
ZHAO Zhong-quan;CHEN Jie-chao;JI Jing-bo;WANG Guang-zhong(Department of Orthopedics, Liaocheng Third People's Hospital, Liaocheng, Shandong Province, 252000 China;Department of Child Protection, Maternal and Child Health Care Hospital of Dongchangfu District,Liaocheng,Shandong Province,252000 China)
出处
《系统医学》
2019年第15期87-90,共4页
Systems Medicine
关键词
塞来昔布
骨创伤治疗仪
膝骨关节炎
疼痛
Celebrex
Bone trauma therapy instrument
Knee osteoarthritis
Pain
